These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37808450)

  • 1. Stakeholder Involvement in the Governance of Human Genome Editing in Japan.
    Aikyo T; Kogetsu A; Kato K
    Asian Bioeth Rev; 2023 Oct; 15(4):431-455. PubMed ID: 37808450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An imbalanced approach to governance? An analysis of the WHO's position on human genome editing.
    Thaldar D; Shozi B
    Bioethics; 2023 Sep; 37(7):656-661. PubMed ID: 37329575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsible governance of human germline genome editing in China†.
    Peng Y; Lv J; Ding L; Gong X; Zhou Q
    Biol Reprod; 2022 Jul; 107(1):261-268. PubMed ID: 35640230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A New Governance Approach to Regulating Human Genome Editing.
    Conley JM; Davis AM; Henderson GE; Juengst ET; Meagher KM; Walker RL; Waltz M; Cadigan J
    N C J Law Technol; 2020 Dec; 22(2):107-141. PubMed ID: 34737680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human genome editing in clinical applications: Japanese lay and expert attitudes.
    Sawai T; Hatta T; Akatsuka K; Fujita M
    Front Genet; 2023; 14():1205092. PubMed ID: 37662845
    [No Abstract]   [Full Text] [Related]  

  • 6. Toward Anticipatory Governance of Human Genome Editing: A Critical Review of Scholarly Governance Discourse.
    Nelson JP; Selin CL; Scott CT
    J Responsible Innov; 2021; 8(3):382-420. PubMed ID: 35281674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Researching the future: scenarios to explore the future of human genome editing.
    Selin C; Lambert L; Morain S; Nelson JP; Barlevy D; Farooque M; Manley H; Scott CT
    BMC Med Ethics; 2023 Sep; 24(1):72. PubMed ID: 37735670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human genome editing: how to prevent rogue actors.
    Townsend BA
    BMC Med Ethics; 2020 Oct; 21(1):95. PubMed ID: 33023591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioethics governance in Israel: an expert regime.
    Shalev C; Hashiloni-Dolev Y
    Indian J Med Ethics; 2011; 8(3):157-60. PubMed ID: 22106642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How should China set ethical guardrails for medical research?
    Xu J; Liu Z; Shi J; Wang Y
    J Med Ethics; 2024 Oct; 50(11):744-748. PubMed ID: 38124192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seven open questions in the futures of human genome editing.
    Nelson JP; Selin CL
    Futures; 2023 May; 149():. PubMed ID: 37484876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public involvement in health research systems: a governance framework.
    Miller FA; Patton SJ; Dobrow M; Berta W
    Health Res Policy Syst; 2018 Aug; 16(1):79. PubMed ID: 30081919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethics and Global Governance of Human Germline Genome Editing: The Problem of Techno-Scientific Colonialist Paternalism.
    Arguedas-Ramírez G
    CRISPR J; 2020 Apr; 3(2):83-88. PubMed ID: 32315224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heritable Genome Editing in a Global Context: National and International Policy Challenges.
    Rosemann A; Balen A; Nerlich B; Hauskeller C; Sleeboom-Faulkner M; Hartley S; Zhang X; Lee N
    Hastings Cent Rep; 2019 May; 49(3):30-42. PubMed ID: 31269262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Walking a Fine Germline: Synthesizing Public Opinion and Legal Precedent to Develop Policy Recommendations for Heritable Gene-Editing.
    Benston S
    J Bioeth Inq; 2022 Sep; 19(3):421-431. PubMed ID: 35438443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative analysis of attitudes toward genome-edited food among Japanese public and scientific community.
    Shineha R; Takeda KF; Yamaguchi Y; Koizumi N
    PLoS One; 2024; 19(4):e0300107. PubMed ID: 38625915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why Include the Public in Genome Editing Governance Deliberation?
    Blasimme A
    AMA J Ethics; 2019 Dec; 21(12):E1065-1070. PubMed ID: 31876471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local health governance in Tajikistan: accountability and power relations at the district level.
    Jacobs E; Baez Camargo C
    Int J Equity Health; 2020 Mar; 19(1):30. PubMed ID: 32122333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Governance of Heritable Human Gene Editing World-Wide and Beyond.
    Xue Y; Shang L
    Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35682323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory and governance gaps for human genome editing in Mexico.
    Aquino-Jarquin G
    Trends Biotechnol; 2024 Jun; 42(6):665-670. PubMed ID: 38129214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.